Bayer Settles Roundup Cancer Suits for Over $10 Billion
In one of the largest civil settlements in U.S. history, Bayer agreed Wednesday to pay more than $10 billion to resolve around 95,000 cases claiming its glyphosate-based weedkiller Roundup causes cancer.
The deal will still allow Bayer to sell Roundup without adding any warnings, The New York Times reported.
It comes after three juries in early, high-profile trials awarded more
than $2.4 billion to plaintiffs who developed non-Hodgkin’s lymphoma
after long term Roundup use.